{
  "main_header": {
    "sid": 1000215,
    "name": "Ganga Pharma.",
    "stock_name": "Ganga Pharma.",
    "full_name": "Ganga Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/ganga-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "12.00",
    "mcapval": "8.00 Cr",
    "mcap": "",
    "scripcode": 539680,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE615T01017",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": 16000,
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ganga-pharma-1000215-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1000215",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/ganga-pharmaceuticals-1000215"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.",
      "datetime": "07-Nov-2025",
      "details": "Un-audited financial results of the Company for the half year ended on September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "07-Nov-2025",
      "details": "Statement of Deviation or Variation for the half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News